Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 2
2007 1
2008 3
2009 3
2010 3
2011 1
2012 2
2013 3
2014 3
2015 2
2016 5
2018 5
2019 3
2020 4
2021 11
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiota and Alcoholic Liver Disease.
Scarpellini E, Forlino M, Lupo M, Rasetti C, Fava G, Abenavoli L, De Santis A. Scarpellini E, et al. Among authors: de santis a. Rev Recent Clin Trials. 2016;11(3):213-9. doi: 10.2174/1574887111666160810100538. Rev Recent Clin Trials. 2016. PMID: 27515958 Review.
Management of refractory typical GERD symptoms.
Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J. Scarpellini E, et al. Among authors: de santis a. Nat Rev Gastroenterol Hepatol. 2016 May;13(5):281-94. doi: 10.1038/nrgastro.2016.50. Epub 2016 Apr 14. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27075264 Review.
The human gut microbiota and virome: Potential therapeutic implications.
Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A. Scarpellini E, et al. Among authors: de santis a. Dig Liver Dis. 2015 Dec;47(12):1007-12. doi: 10.1016/j.dld.2015.07.008. Epub 2015 Jul 18. Dig Liver Dis. 2015. PMID: 26257129 Free PMC article. Review.
Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
Ferri F, Mischitelli M, Tozzi G, Messina E, Mignini I, Mazzuca S, Pellone M, Parisse S, Marrapodi R, Visentini M, Baratta F, Del Ben M, Pastori D, Perciballi R, Attilia ML, Carbone M, De Santis A, Violi F, Angelico F, Ginanni Corradini S. Ferri F, et al. Among authors: de santis a. Clin Transl Gastroenterol. 2020 Feb;11(2):e00116. doi: 10.14309/ctg.0000000000000116. Clin Transl Gastroenterol. 2020. PMID: 32463622 Free PMC article.
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
de Salazar A, Dietz J, di Maio VC, Vermehren J, Paolucci S, Müllhaupt B, Coppola N, Cabezas J, Stauber RE, Puoti M, Arenas Ruiz Tapiador JI, Graf C, Aragri M, Jimenez M, Callegaro A, Pascasio Acevedo JM, Macias Rodriguez MA, Rosales Zabal JM, Micheli V, Garcia Del Toro M, Téllez F, García F, Sarrazin C, Ceccherini-Silberstein F; GEHEP-004 cohort, the European HCV Resistance Study Group and the HCV Virology Italian Resistance Network (VIRONET C). de Salazar A, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3349-3358. doi: 10.1093/jac/dkaa304. J Antimicrob Chemother. 2020. PMID: 32772078
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.
Lanini S, Scognamiglio P, Mecozzi A, Lombardozzi L, Vullo V, Angelico M, Gasbarrini A, Taliani G, Attili AF, Perno CF, De Santis A, Puro V, Cerqua F, D'Offizi G, Pellicelli A, Armignacco O, Mennini FS, Siciliano M, Girardi E, Panella V, Ippolito G; members of the Lazio Region HCV treatment group. Lanini S, et al. Among authors: de santis a. BMC Infect Dis. 2018 May 16;18(1):223. doi: 10.1186/s12879-018-3125-6. BMC Infect Dis. 2018. PMID: 29769038 Free PMC article.
50 results